The adoption of digital medicine, also known as digital therapy, was challenging before the pandemic. Clinical validation and FDA approval have gradually changed how these treatments are viewed. However, the need for remote patient monitoring of chronic diseases during the Covid-19 pandemic has led to increased interest in the field and hopes that it will continue to outperform the pandemic.
Many of the digital medicines available are designed to address behavioral health needs. Increased social isolation associated with the Covid-19 pandemic may lead to stress, depression, anxiety and substance abuse.
The future of digital medicine is just one of the panel discussions MedCity will offer Invest in medical technology, a virtual conference scheduled for July 26. It will bring together technology disruptors, Big Pharma and biotech leaders, investors and entrepreneurs to discuss how digital strategies can be employed to transform every aspect of the pharmaceutical industry.
To register for free, click here.
Digital medicine has a bright future. A new generation of companies aims to transform the digital therapeutics market. Learn from experts in pharma, digital health and commercialization.
Panel speakers include:
The panel discussion will conclude with the launch of the pitch competition.The pitch-perfect theme for this mini is Reinventing clinical trials. The application deadline is May 31st. To apply, click here.
Apply to be a spokesperson for INVEST PharmaTech, follow this link. The application deadline is May 26.
For information on sponsoring sessions from panel discussions to video spotlights, please email: Advertisement @medcitynews.com
photo: Who_I_am, Getty Images
